Literature DB >> 2374682

Surgical management of the idiopathic uveal effusion syndrome.

M W Johnson1, J D Gass.   

Abstract

Twenty-three eyes of 20 patients with idiopathic ciliochoroidal effusion underwent quadrantic partial-thickness sclerectomies without decompression of the vortex veins. The mean postoperative follow-up interval was 41 months (range, 6-86 months). Resolution of subretinal and/or supraciliochoroidal fluid occurred within 6 months in 19 eyes (83%) after one procedure and in 22 eyes (96%) after one or two procedures. The mean interval to reattachment for the 19 successfully treated eyes with nonrhegmatogenous retinal detachment (RD) was 2.4 months compared with an average preoperative detachment duration of 18.5 months (P = 0.0005). Recurrences were seen in 23% of eyes; all resolved spontaneously or with a single reoperation. Final visual acuity was improved by two or more lines in 13 eyes (56%), stable in 8 (35%), and worse in 2 (9%). The efficacy of this surgical technique supports the hypothesis that an abnormality of transscleral protein transport plays a primary pathophysiologic role in this disorder.

Entities:  

Mesh:

Year:  1990        PMID: 2374682     DOI: 10.1016/s0161-6420(90)32511-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  12 in total

1.  [Choroidal tumor with exsudative retinal detachment?].

Authors:  T Brauns; F Höhn; L-O Hattenbach
Journal:  Ophthalmologe       Date:  2012-02       Impact factor: 1.059

2.  Uveal effusion syndrome mimicking severe chronic posterior uveitis: a case series of seven eyes of four patients.

Authors:  Emilia Maggio; Antonio Polito; Guido Prigione; Grazia Pertile
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-09-16       Impact factor: 3.117

3.  Clinical characteristics and surgical treatment of idiopathic uveal effusion syndrome.

Authors:  Zhi-Jun Shen; Lin Shen; Hong Wang
Journal:  Int J Ophthalmol       Date:  2022-04-18       Impact factor: 1.779

4.  Uveal Effusion Syndrome: Clinical Characteristics, Outcome of Surgical Treatment, and Histopathological Examination of the Sclera.

Authors:  Nan Zhou; Lihong Yang; Xiaolin Xu; Wenbin Wei
Journal:  Front Med (Lausanne)       Date:  2022-06-09

5.  Glaucoma in a patient with nanophthalmos.

Authors:  Kouros Nouri-Mahdavi; Naveed Nilforushan; Mohammad-Reza Razeghinejad; Heydar Amini; Shamira A Perera
Journal:  J Ophthalmic Vis Res       Date:  2011-07

6.  Full-thickness sclerotomy for uveal effusion syndrome.

Authors:  Mingui Kong; Jae Hui Kim; Sang Jin Kim; Se Woong Kang
Journal:  Korean J Ophthalmol       Date:  2013-06-28

7.  Uveal effusion syndrome in 104 eyes: Response to corticosteroids - The 2017 Axel C. Hansen lecture.

Authors:  Carol L Shields; Kelsey Roelofs; Maura Di Nicola; Kareem Sioufi; Arman Mashayekhi; Jerry A Shields
Journal:  Indian J Ophthalmol       Date:  2017-11       Impact factor: 1.848

8.  Geographic filling delay of the choriocapillaris in the region of dilated asymmetric vortex veins in central serous chorioretinopathy.

Authors:  Shoji Kishi; Hidetaka Matsumoto; Shozo Sonoda; Takashi Hiroe; Taiji Sakamoto; Hideo Akiyama
Journal:  PLoS One       Date:  2018-11-09       Impact factor: 3.240

9.  Inhibition of β-site amyloid precursor protein cleaving enzyme 1 and cholinesterases by pterosins via a specific structure-activity relationship with a strong BBB permeability.

Authors:  Susoma Jannat; Anand Balupuri; Md Yousof Ali; Seong Su Hong; Chun Whan Choi; Yun-Hyeok Choi; Jin-Mo Ku; Woo Jung Kim; Jae Yoon Leem; Ju Eun Kim; Abinash Chandra Shrestha; Ha Neul Ham; Kee-Ho Lee; Dong Min Kim; Nam Sook Kang; Gil Hong Park
Journal:  Exp Mol Med       Date:  2019-02-12       Impact factor: 8.718

10.  The treatment of malignant glaucoma in nanophthalmos: a case report.

Authors:  Jie Wang; Ergang Du; Jinfei Tang
Journal:  BMC Ophthalmol       Date:  2018-02-23       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.